Company / AR per Share
Vanda Pharmaceuticals Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.94
FY2025
5-year range
$0.59 / $0.94
FY2021-FY2025
Trend
+14.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has increased for 6 consecutive years, from $0.50 in FY2019 to $0.94 in FY2025.
Based on SEC 10-K filings.
0.94 in FY2025 with a 5-year CAGR of +10.8%.
Improved from $0.60 to $0.94 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s ar per share has grown for 6 consecutive years.
- In FY2025, ar per share increased 14.3% year-over-year.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.94 | +14.3% |
| FY2024 | $0.82 | +36.1% |
| FY2023 | $0.60 | +0.3% |
| FY2022 | $0.60 | +1.3% |
| FY2021 | $0.59 | +5.5% |
| FY2020 | $0.56 | +11.6% |
| FY2019 | $0.50 | -21.5% |
| FY2018 | $0.64 | +60.1% |
| FY2017 | $0.40 | -15.5% |
| FY2016 | $0.47 | +20.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026